[Federal Register Volume 83, Number 239 (Thursday, December 13, 2018)]
[Notices]
[Pages 64134-64135]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-26960]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and/or contract proposals 
and the discussions could disclose confidential trade secrets or 
commercial property such as patentable material, and personal 
information concerning individuals associated with grant and/or 
contract proposals applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI UG1 and U24 Chemoprevention Clinical Trials Network.
    Date: January 15, 2019.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 7W102, Rockville, MD 20850, (Telephone Conference 
Call).
    Contact Person: Shakeel Ahmad, Ph.D., Scientific Review Officer, 
Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W102, Bethesda, MD 20892-9750, 240-276-6349, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; TEP-2: SBIR Contract Review.
    Date: February 6, 2019.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 7W102, Rockville, MD 20850, (Telephone Conference 
Call).
    Contact Person: Shakeel Ahmad, Ph.D., Scientific Review Officer, 
Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W102, Bethesda, MD 20892-9750, 240-276-6349, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; TEP-5: SBIR Contract Review.
    Date: February 21, 2019.
    Time: 8:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 6E034, Rockville, MD 20850, (Telephone Conference 
Call).
    Contact Person: Nadeem Khan, Ph.D., Scientific Review Officer, 
Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W260, Bethesda, MD 20892-9750, 240-276-5856, 
[email protected].

    Name of Committee: National Cancer Institute Initial Review 
Group; Subcommittee I--Transition to Independence.
    Date: February 21-22, 2019.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, Bethesda, MD 20852.
    Contact Person: Delia Tang, M.D., Scientific Review Officer, 
Research Programs Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W602, Bethesda, MD 20892-9750, 240-276-6456, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; R25 Review.
    Date: March 6, 2019.
    Time: 1:00 p.m. to 4:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 7W110, Rockville, MD 20850, (Telephone Conference 
Call).
    Contact Person: Robert E. Bird, Ph.D., Scientific Review 
Officer, Research Program Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W110, Bethesda, MD 20892-9750, 240-276-6344, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; UH2/UH3 Review.
    Date: March 7, 2019.
    Time: 1:00 p.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 7W110, Rockville, MD 20850, (Telephone Conference 
Call).
    Contact Person: Robert E. Bird, Ph.D., Scientific Review 
Officer, Research Program Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W110, Bethesda, MD 20892-9750, 240-276-6344, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; SEP-8: NCI Clinical and Translational R21 and Omnibus R03.
    Date: March 7-8, 2019.
    Time: 6:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, North Bethesda, MD 20852.
    Contact Person: Reed Graves, Ph.D., Scientific Review Officer, 
Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W106, Bethesda, MD 20892-9750, 240-276-6384, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Informatics Tools for Cancer Research and Surveillance.
    Date: March 21-22, 2019.
    Time: 5:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, North Bethesda, MD 20852.
    Contact Person: Nadeem Khan, Ph.D., Scientific Review Officer, 
Research Technology and Contract Review Branch, Division of 
Extramural Activities, National

[[Page 64135]]

Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W260, 
Bethesda, MD 20892-9750, 240-276-5856, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; TEP-6: SBIR Contract Review.
    Date: April 18, 2019.
    Time: 10:00 a.m. to 7:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 7W106, Rockville, MD 20850, (Telephone Conference 
Call).
    Contact Person: Reed Graves, Ph.D., Scientific Review Officer, 
Special Review Branch, Division of Extramural Activities, National 
Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W106, 
Bethesda, MD 20892-9750, 240-276-6384, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: December 7, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-26960 Filed 12-12-18; 8:45 am]
 BILLING CODE 4140-01-P